Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells.

Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, Moretto P, Heldin P, Hascall VC, De Luca G, Passi A.

J Biol Chem. 2011 Mar 11;286(10):7917-24. doi: 10.1074/jbc.M110.193656. Epub 2011 Jan 12.

2.

The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells.

Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, Clerici M, Bartolini B, Hascall VC, De Luca G, Passi A.

Glycobiology. 2009 May;19(5):537-46. doi: 10.1093/glycob/cwp022. Epub 2009 Feb 24.

PMID:
19240269
3.

Metabolic control of hyaluronan synthases.

Vigetti D, Viola M, Karousou E, De Luca G, Passi A.

Matrix Biol. 2014 Apr;35:8-13. doi: 10.1016/j.matbio.2013.10.002. Epub 2013 Oct 14. Review.

4.

Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging.

Vigetti D, Viola M, Karousou E, Rizzi M, Moretto P, Genasetti A, Clerici M, Hascall VC, De Luca G, Passi A.

J Biol Chem. 2008 Feb 15;283(7):4448-58. Epub 2007 Dec 12.

5.

Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis.

Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall VC, Tammi M, De Luca G, Passi A.

J Biol Chem. 2012 Oct 12;287(42):35544-55. doi: 10.1074/jbc.M112.402347. Epub 2012 Aug 10.

6.

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.

Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y.

Circulation. 2004 Jul 27;110(4):444-51. Epub 2004 Jul 19.

7.

Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis.

Grandoch M, Hoffmann J, Röck K, Wenzel F, Oberhuber A, Schelzig H, Fischer JW.

Basic Res Cardiol. 2013 Mar;108(2):340. doi: 10.1007/s00395-013-0340-6. Epub 2013 Feb 26.

PMID:
23440385
8.

Oxidized low density lipoprotein (LDL) affects hyaluronan synthesis in human aortic smooth muscle cells.

Viola M, Bartolini B, Vigetti D, Karousou E, Moretto P, Deleonibus S, Sawamura T, Wight TN, Hascall VC, De Luca G, Passi A.

J Biol Chem. 2013 Oct 11;288(41):29595-603. doi: 10.1074/jbc.M113.508341. Epub 2013 Aug 26.

9.

Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway.

Sung JY, Choi HC.

Vascul Pharmacol. 2012 Jan-Feb;56(1-2):1-8. doi: 10.1016/j.vph.2011.06.001. Epub 2011 Jun 25.

PMID:
21708289
10.

Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.

Rilla K, Oikari S, Jokela TA, Hyttinen JM, Kärnä R, Tammi RH, Tammi MI.

J Biol Chem. 2013 Feb 22;288(8):5973-83. doi: 10.1074/jbc.M112.443879. Epub 2013 Jan 9.

11.
12.

AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.

Davis B, Rahman A, Arner A.

Eur J Pharmacol. 2012 Nov 15;695(1-3):88-95. doi: 10.1016/j.ejphar.2012.07.025. Epub 2012 Aug 19.

PMID:
22921370
13.

Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Twarock S, Freudenberger T, Poscher E, Dai G, Jannasch K, Dullin C, Alves F, Prenzel K, Knoefel WT, Stoecklein NH, Savani RC, Homey B, Fischer JW.

Mol Cancer. 2011 Mar 23;10:30. doi: 10.1186/1476-4598-10-30.

14.

Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis.

Sainio A, Jokela T, Tammi MI, Järveläinen H.

Glycobiology. 2010 Sep;20(9):1117-26. doi: 10.1093/glycob/cwq076. Epub 2010 May 20.

PMID:
20488939
15.

Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells.

Papakonstantinou E, Klagas I, Karakiulakis G, Hostettler K, S'ng CT, Kotoula V, Savic S, Tamm M, Roth M.

Am J Respir Cell Mol Biol. 2012 Dec;47(6):759-67. doi: 10.1165/rcmb.2012-0101OC. Epub 2012 Aug 3.

PMID:
22865625
16.
17.

AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.

Chang MY, Ho FM, Wang JS, Kang HC, Chang Y, Ye ZX, Lin WW.

Biochem Pharmacol. 2010 Oct 15;80(8):1210-20. doi: 10.1016/j.bcp.2010.06.049. Epub 2010 Jul 6.

PMID:
20615388
19.

Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt.

Kultti A, Kärnä R, Rilla K, Nurminen P, Koli E, Makkonen KM, Si J, Tammi MI, Tammi RH.

J Biol Chem. 2010 Jul 23;285(30):22901-10. doi: 10.1074/jbc.M109.088435. Epub 2010 May 25.

20.

Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells.

Vigetti D, Rizzi M, Moretto P, Deleonibus S, Dreyfuss JM, Karousou E, Viola M, Clerici M, Hascall VC, Ramoni MF, De Luca G, Passi A.

J Biol Chem. 2011 Oct 7;286(40):34497-503. doi: 10.1074/jbc.M111.266312. Epub 2011 Jul 18.

Supplemental Content

Support Center